CARBIOS announces fiscal-year 2023 financial results and confirms
2024 calendar for industrial and commercial roll-out
- CARBIOS Group’s solid
financial structure: cash position of €192 million on December 31,
2023
- Construction progress of
world’s first PET1 biorecycling
plant in France: in line with delivery targets for customers in
2026
-
Licensing: international sales teams deployed in more than
ten countries, with several partnerships feasible for
2024
Clermont-Ferrand, France, April 11, 2024
(6:45 a.m. CEST) - CARBIOS
(Euronext Growth Paris: ALCRB), a biotech company
developing and industrializing biological solutions to reinvent the
life cycle of plastic and textiles, today reported its operating
and financial results for the financial year 2023. The financial
statements as of December 31, 2023, were approved by the Company’s
Board of Directors at their meeting on April 10, 2024.
Emmanuel Ladent, CEO of
CARBIOS: “2023 was marked by major scientific and
operational achievements, most prominently, the start of the
construction, in France, of the world’s first industrial PET
biorecycling plant which is due to go into production in 2026 and
will serve the many customers who expect our products. We also
signed a mutually exclusive alliance with Novonesis ensuring enzyme
supply for our Longlaville plant and all future plants operated
under license. In addition, we reached an important milestone for
the recycling of polyester textiles with the development and
implementation of a fully automated and integrated textile
preparation line. I would like to thank the commitment of our
employees, as well as all our partners’ contributions in making
CARBIOS a future world leader in the r-PET market.”
Pascal Bricout, Chief of Strategy and
Financial Officer of CARBIOS: “In fiscal year 2023, we
consolidated our financial structure to support the industrial and
commercial deployment of our technologies and accelerate our
R&D on other polymer families, notably polyamides and
polyolefins. We successfully completed a capital increase with
preferential subscription rights for a gross amount of €141
million, the largest fundraising on Euronext Growth since 2015. In
addition, we were granted funding totaling €54 million from French
State via France 2030 and Grand-Est Region, of the majority of
which will be allocated to the construction of our plant in
Longlaville. The official groundbreaking ceremony will take place
on 25 April. We now have the resources required to press ahead with
the construction of our first plant and ensure the commercial and
international deployment of our activities.”
A webcast and
conference call will take place today at 11:00 am
(CEST)
Emmanuel LADENT – CEO /
Pascal BRICOUT – Chief of Strategy and Finance
Access to the
webcast: https://edge.media-server.com/mmc/p/cyrcdmu8
France Dial-in: +33
170918704 UK
Dial-in: +44 1
212818004 US
Dial-in: +1 718 7058796
2023 Financial highlights
The consolidated financial statements of the
Company as of December 31, 2023, are presented in accordance with
International Financial Reporting Standards (IFRS) as issued by the
International Accounting Standards Board (IASB) and adopted by the
European Union.
For 2022 and 2023,
these IFRS consolidated financial statements include the financial
statements of CARBIOS, the parent company, and the financial
statements of its fully integrated subsidiaries Carbiolice and
CARBIOS 542. The group formed by CARBIOS, Carbiolice and CARBIOS 54
is hereinafter referred to as the “Group”.
These IFRS financial
statements for the Group have been prepared to provide high quality
information in line with that of similar companies and based on
international standards.
Consolidated Statement of income
Consolidated statement of income (in
thousand euros) |
|
December31, 2023 |
December 31, 2022 |
|
|
12 months |
12 months |
Income |
|
24 |
70 |
Net Research
and Development expenses |
|
(10,958) |
(12,993) |
Research and Development expenses |
|
(18,830) |
(19,057) |
Subsidies and other income from activities |
|
5,385 |
4,776 |
Capitalisation of development costs |
|
2,487 |
1,287 |
Sales and
marketing expenses |
|
(5,809) |
(4,373) |
General and administrative expenses |
|
(12,134) |
(8,807) |
Operating expenses |
|
(28,902) |
(26,173) |
Other operating income and expenses |
|
- |
2 |
Operating income |
|
(28,878) |
(26,101) |
Financial income |
|
1,655 |
(1,640) |
Income before tax |
|
(27,224) |
(27,741) |
Income tax |
|
- |
- |
Share and profit (loss) of equity affiliates |
|
- |
- |
Net income (loss) for the period |
|
(27,224) |
(27,741) |
- Income according to IFRS 15
standards
For the financial years 2022 and 2023, income
accounted under IFRS 15 is related to feasibility studies, tests,
and research services with performance obligation, as well as
deliveries of raw materials and samples of CARBIOS Active by
Carbiolice.
As of December 31, 2023, the Group’s income
stood at €24 thousand, compared to €70 thousand for the year ended
December 31, 2022.
- Current operating
expenses
With regards to the presentation of its IFRS
consolidated statements, the Group shows a statement of income by
destination. Thus, current operating expenses are categorized and
presented as: Net Research and Development expenses, Sales and
Marketing expenses, as well as General and Administrative
expenses.
Operating expenses stood at €28,902 thousand for
2023, compared to €26,173 thousand in 2022.
To support the growth of its activities, the
average number of employees within the Group increased from 104 in
2022 to 134 in 2023.
Net Research and Development expenses: The Group
pursued its research and development efforts on all its proprietary
pipeline of innovations and notably on its biorecycling technology
for PET plastic and polyester fibers. For 2023, the Group’s Net
R&D expenses stood at €10,958 thousand, compared to €12,993
thousand for 2022.
For FY 2023:
- On R&D, the Group spent €18,958
thousand. The slight decrease in R&D expenses is mainly due to
the launch of the OPTI-ZYME project financed by ADEME, under which
the Group’s academic partners are funded directly through the
project. In addition, as the plant construction project has
progressed, engineering costs are no longer accounted as expenses
but capitalized directly to fixed asset accounts. Also, to
successfully complete its R&D and industrial projects, the
Company is continuing to strengthen its teams, which explains the
increase in personnel costs.
- On Subsidies and other income from
operations, the Group recorded €5,385 thousand, partially
offsetting its R&D expenses. This item includes notably
research tax credits to be received of respectively €2,543 thousand
for CARBIOS and €672 thousand for Carbiolice in 2023 (as opposed to
respectively €2,538 thousand and €655 thousand in 2022), as well as
grants received during the year linked to the launch of the
OPTI-ZYME project financed by ADEME.
- Finally, the Group has capitalized
€2,487 thousand development expenses related to the Company’s PET
enzymatic recycling project in 2023.
Sales and Marketing expenses: Sales and
marketing expenses stood at €5,809 thousand in 2023, compared to
€4,373 thousand in 2022. This increase mainly comes from
strengthened efforts to address market demand and sell licences in
a near future. The Group is also continuing its structuring work
with a reinforcement of its teams to achieve its development goals
in France and internationally.
General and Administrative expenses: General and
administrative expenses stood at €12,134 thousand in 2023, as
opposed to €8,807 thousand in 2022. This increase is mainly due to
the strengthening of the teams dedicated to the Longlaville plant
construction and increased use of external consulting services to
continue structuring the Group in a variety of areas (recruitment,
QHSE, CSR, IT, etc.)
Balance Sheet items
Consolidated statement of financial
position(in thousand euros) |
|
December31, 2023 |
|
December31, 2022 |
|
|
12 months |
|
12 months |
|
ASSETS |
|
|
|
|
|
|
|
|
|
|
|
Goodwill |
|
20,583 |
|
20,583 |
|
Intangible
assets |
|
21,874 |
|
22,457 |
|
Tangible
assets |
|
49,199 |
|
24,965 |
|
Right-of-use
assets |
|
6,175 |
|
6,765 |
|
Financial
assets |
|
1,219 |
|
906 |
|
Non-current assets |
|
99,049 |
|
75,674 |
|
|
|
|
|
|
|
Trade
receivables |
|
6 |
|
57 |
|
Inventory |
|
511 |
|
- |
|
Other current
assets |
|
10,621 |
|
7,670 |
|
Cash and cash
equivalents |
|
191,821 |
|
100,557 |
|
Current assets |
|
202,009 |
|
108,284 |
|
|
|
|
|
|
|
Total assets |
|
302,009 |
|
183,959 |
|
Consolidated statement of financial position
(in thousand euros) |
|
December31, 2023 |
|
December31, 2022 |
|
|
|
|
|
|
EQUITY
AND LIABILITIES |
|
|
|
|
|
|
|
|
|
|
|
Share
capital |
|
11,786 |
|
7,870 |
|
Share and
contribution premium |
|
276,569 |
|
146,968 |
|
Consolidated
reserves |
|
(2,900) |
|
(5,482) |
|
Retained
earnings |
|
(23,917) |
|
3,826 |
|
Net
income – share attributable to equity holders of the parent
company |
|
(27,224) |
|
(27,741) |
|
|
|
|
|
Shareholders’ equity |
|
234,314 |
|
125,441 |
|
|
|
|
|
|
|
Provisions –
Non-current portion |
|
216 |
|
184 |
|
Loans and
financial liabilities – Non-current portion |
|
39,226 |
|
35,395 |
|
Lease
liabilities – Non-current portion |
|
4,639 |
|
5,142 |
|
Other
liabilities – Non-current portion |
|
449 |
|
546 |
|
Deferred tax
liabilities |
|
1,694 |
|
1,694 |
|
Non-current liabilities |
|
46,224 |
|
42,961 |
|
|
|
|
|
|
|
Provisions -
Current portion |
|
- |
|
- |
|
Loans and
financial liabilities – Current portion |
|
3,524 |
|
2,782 |
|
Lease
liabilities – Current portion |
|
1,232 |
|
1,346 |
|
Trade
payables |
|
4,829 |
|
4,021 |
|
Other current
liabilities |
|
11,888 |
|
7,408 |
|
Current liabilities |
|
21,472 |
|
15,557 |
|
|
|
|
|
|
|
Total liabilities and equity |
|
302,009 |
|
183,959 |
|
As of December 31, 2023, cash and cash
equivalents amounted to €192 million, compared to €101 million for
the year ended December 31, 2022.
The other key balance sheet items as of December
31, 2023 are:
- €20,6 million corresponding to the
Goodwill calculated between the market value of Carbiolice and the
net assets acquired; the impairment tests carried out in 2023 do
not call this amount into question.
- Intangible assets for a net book
value of €21.9 million for the year ended December 31, 2023.
Pursuing on its active policy of securing its
Intellectual Property, CARBIOS continued to enrich its IP portfolio
with the filing of 5 new patent families. The Group’s intellectual
property portfolio at the end of 2023 included 58 patent
families.As a result of the full integration of Carbiolice in 2021,
€22.3 million were also recognized for the purchase price of
Carbiolice, with a net amortization position of €18 million as of
December 31, 2023, including:
- €10.1 million net (€12.5 million
gross) for the technology license (or “reacquired rights”). Under
IFRS 3, the technology license between CARBIOS and Carbiolice is
assimilated to a pre-existing relationship giving rise to the
recognition of a “reacquired rights” asset that has been valued
using the expected cash flow method; and
- €7.9 million net (€9.8 million
gross) market value of the acquired technology (Masterbatch) valued
using the royalty and restoration cost method.
- Tangible assets for a net book
value of €49.2 million, as compared to €25 million for the year
ended December 31, 2022.
This strong increase
is mainly due to:
- €21 million investment related to
the construction project of the first PET biorecycling plant
through CARBIOS 54;
- continued investment in the
industrial demonstration facility. These tangible assets also
include leasebacks relating to the industrial demonstration
facility. As of December 31, 2023, the operation covers €4.3
million of equipment depreciated over 10 years, in addition to the
€1.5 million for the previous year; and
- €2.1 million invested in renovating
the building housing the production line of Carbiolice and the
textile preparation line, at the Cataroux site in
Clermont-Ferrand.
- Rights-of-use asset for a net book
value of €6.2 million corresponding to the market value of the
tangible and intangible assets benefiting to the Group through its
various lease contracts. In return, “lease debts” are recorded on
the liabilities side of the balance sheet as financing for these
assets; and
- Shareholder’s equity of €234.3
million, including the net proceeds of the €141 million capital
increase successfully completed in July 2023 with French and
International investors, as compared to €125.4 million for the year
ended December 31, 2022.
Cash flow statement
Consolidated cash flow statement (in thousand
euros) |
|
December31, 2023 |
|
December31, 2022 |
|
|
|
|
|
Cash at beginning of year |
|
100,556 |
|
104,956 |
Cash flow from operating activities |
|
(22,589) |
|
(21,820) |
Cash flow from investing activities |
|
(22,391) |
|
(9,327) |
Cash flow from financing activities |
|
136,246 |
|
26,747 |
Change in cash position |
|
91,265 |
|
(4,398) |
Cash at end of year |
|
191,821 |
|
100,557 |
Benefiting from the net proceeds of the €141
million raised in 2023, the Group closed out with a net cash
position of €192 million at year-end 2023, enabling it to pursue
current developments beyond the next 12 months.
FY 2023 and post-closing highlights
Construction of the world’s first industrial PET
biorecycling plant in France
In fiscal year 2023,
we have established the necessary partnerships to successfully
build the world's first PET biorecycling plant in France. This
industrial plant, which is currently under construction in
Longlaville (permit granted in October 2023 and groundbreaking
ceremony to be held on April 25, 2024) is located at the borders of
Luxembourg, Germany and Belgium, some of the most advanced
waste-sorting countries. It is designed to process 50,000 tons of
PET waste annually, equivalent to 2 billion bottles or 2.5 billion
food trays. This plant will also serve to bolster the Company's
business model of licensing its technology to manufacturers who
will build their own plants, as well as reinforce the Company's
know-how in its industrial and commercial deployment strategy
through international licensing.
In June 2023, we
signed a non-binding Memorandum of Understanding
(“MOU”) with Indorama Ventures,
with a view to acquiring a minority stake in this first PET
biorecycling plant.
In October 2023, we
were granted the building permit and
operating authorization for the PET biorecycling plant,
allowing construction to start. In addition, in February 2024,
we completed the acquisition from Indorama
Ventures of a 13.7-hectare site adjacent to their
existing PET production plant in Longlaville. The land
area acquired by CARBIOS gives the possibility to double the
facility's capacity.
By simultaneously acquiring construction and
operating permits, construction work as well as recruitment and
training of plant staff can continue as planned. The
state-of-the-art facility will pave the way for PET circular
economy by providing an industrial-scale enzymatic recycling
solution for PET waste. Our PET recycling technology offers an
alternative raw material to virgin fossil-based monomers, allowing
PET producers, chemical companies, waste management firms, public
entities, and brands to meet regulatory requirements and fulfill
given sustainability commitments.
In February 2024, CARBIOS and
De Smet Engineers & Contractors (DSEC)
announced their collaboration to spearhead the
construction of the plant. Under the agreement, De Smet has been
entrusted with the project management and detailed engineering,
including procurement assistance and CARBIOS partners’ management,
to ensure the execution of the plant's construction in Longlaville,
France.
Financing of plant
In May 2023, CARBIOS
announced that its project has been selected by the French
government for funding for an amount of €30 million from
the French State via France 2030 and €12.5 million from the
Grand-Est Region3.
Alongside this
support, CARBIOS has been granted total funding of €11.4
million from the French State as part of France 2030, of which €8.2
million directly for CARBIOS (€5 million in repayable
advances) and €3.2 million for its academic partners INRAE,
INSA and CNRS via the TWB and TBI joint service and
research units. This funding will enable the Group to continue its
research into the optimization and continuous improvement of
CARBIOS’ enzymatic technologies.
In July 2023, CARBIOS
announced the success of its capital increase in cash with
preferential subscription rights (“PSR”) maintained for a gross
amount of approximately €141 million4. Approximately 85%
of the net proceeds of this capital increase are to be used to
finance the construction of the industrial PET biorecycling plant,
for which the investment was estimated in June 2023 at around €230
million (FEL 3).
Textile preparation line
In October 2023, CARBIOS inaugurated its
textile preparation line at our demonstration plant in
Clermont-Ferrand. Polyester textiles account for 2/3 of
the global PET market of around 100 million tons. Only 13% of
textile waste is currently recycled, and only 1% is recycled
"fiber-to-fiber"5,6. To streamline the textile preparation phase,
CARBIOS has developed a fully integrated and automated line that
transforms textile waste from used garments or cutting scraps into
raw material suitable for depolymerization with its enzymatic
biorecycling process. This patented line integrates all preparation
stages (shredding and extraction of hard points such as buttons or
fasteners), and provides CARBIOS with a high-performance, scalable
development tool.
Other operational highlights
-
Strategic alliance with Novonesis
In January 2023, CARBIOS strengthened its
strategic partnership with Novonesis by signing an
exclusive and long-term agreement which ensures the production and
supply of CARBIOS’ proprietary PET degrading enzymes at industrial
scale for our first plant, as well as for our future licensees.
-
Licensing documentation ready
In April 2023, we finalized the
engineering documentation7 enabling us to provide our
licensees with the necessary information for future industrial
plants. This new industrial milestone on schedule in the deployment
of our PET biorecycling technology is the result of our successful
operations conducted in our demonstration plant and is the starting
point to enter first licensing agreements in 2024. It will enable
CARBIOS’ future licensees to reliably engineer, construct and
operate their own PET biorecycling facilities.
- Supply
agreements secured with Citeo and Landbell Group
In April 2023, we secured a first supply
agreement with Citeo for our PET biorecycling plant. This
long-term agreement covers the supply of PET waste from multilayer
and monolayer trays. This PET waste will be recycled in our
industrial plant, which is due to go into production in 2026.
In February 2024, CARBIOS and
Landbell Group, a leading provider for compliance
solutions and global operator of more than 40 takeback schemes,
announce the signing of a non-binding Memorandum of Understanding
(MOU) to supply 15kt/year of post-consumer PET waste to CARBIOS'
first commercial plant in Longlaville starting 2026.
Through the partnership with Landbell Group in
Germany, the supply agreement with Citeo in France and the MOU with
Indorama Ventures, CARBIOS will have covered over 70% of
its feedstock required for the 50kt/year capacity when its
first commercial plant in Longlaville, France, will operate at full
capacity.
Textile consortium
In February 2023,
PVH Corp., a leading fashion company joined our
fiber-to-fiber consortium founded by CARBIOS with
On, Patagonia, PUMA, and Salomon. Committed to
accelerating the transition of the textile industry toward a
circular economy, consortium members collaborate to test and
enhance CARBIOS’ breakthrough biological recycling technology on
their own products. The common goal of the consortium members is to
create real circularity in this industry by innovating to recycle
fibers from one product into another and so reduce the problem of
textile waste in a collaborative approach that helps create a more
sustainable future.
Ellen
MacArthur Foundation and Paris Good Fashion
In March 2023,
CARBIOS became a member of the Ellen MacArthur Foundation’s
Network. CARBIOS shares the Foundation’s commitment to
accelerate the transition to a circular economy, especially in the
areas of plastic and fashion. By joining the Ellen MacArthur
Foundation’s Network, CARBIOS will connect with other leaders
within the Foundation’s leading circular economy network of
businesses, policymakers, academia, innovators, and thought leaders
worldwide.
In March 2024,
CARBIOS became a member of Paris Good Fashion, the
association that unites over 100 French players in the sector -
brands, designers and experts - around their commitment to
sustainable fashion. CARBIOS is the first recycling technology
supplier to join, demonstrating the importance given to recycling
to achieve textile circularity. CARBIOS will be particularly
involved in the association's project to set up a working group
dedicated to the development of a "fiber-to-fiber" industry, one of
Paris Good Fashion's top priorities over the next five years. While
only 1% of textiles are currently recycled fiber-to-fiber
(circular), this working group will identify levers for
significantly increasing the share of recycled fibers in the
industry.
Technology and
IP update
In February 2023,
CARBIOS successfully validated the final key stage of the
CE-PET research project supported by the French State as
part of the Investments for the Future Program, now integrated into
France 2030, and operated by ADEME, and for which CARBIOS was
coordinator alongside its academic partner INRAE -TWB (Toulouse
Biotechnology Institute). The CE-PET project, which lasted four
years, confirmed CARBIOS ability to enzymatically recycle complex
waste to produce bottles and fibers.
In March 2023,
biotechnology researchers from CARBIOS and its academic partner
Toulouse Biotechnology Institute (TBI), as well as two eminent
professors in polymer science from the University of Bordeaux
published in Chemical Reviews an article entitled “Enzymes’
power for plastics degradation”. The article is a
comprehensive and critical review of research published to date on
the enzymatic degradation of all types of plastics (PET, PLA,
polyolefins, polyurethanes, polyamides) and includes almost 700
references.
In April 2023, we
announced the development of an ultra-high throughput
microfluidic screening of PET-depolymerizing enzymes in
partnership with the Paul Pascal Research Centre (a joint research
unit of the CNRS and the University of Bordeaux,
which specializes in microfluidics). This cutting-edge technology
enables the screening of millions of enzymes in just one day,
speeding up the process to optimize enzymes breaking down
PET. This competitive advantage enables CARBIOS to reduce the
time between the R&D phase and the production of its
proprietary enzymes, and therefore to develop concrete solutions to
plastic pollution even faster.
Also, in October 2023, CARBIOS announced the
publication in ACS Catalysis of an article
entitled "Assessment of Four Engineered PET Degrading Enzymes
Considering Large-Scale Industrial Applications". The
article demonstrates that under industrial conditions CARBIOS'
enzyme LCCICCG (published in Nature in 2020) outperforms all three
competitors considered most promising in scientific literature: two
variants of the IsPETase enzyme produced by Ideonella sakaiensis
described by the University of Manchester and the University of
Austin (Texas) and a variant of PES-H1 (also known as PHL7)
described by the University of Greifswald.
As of today, CARBIOS’ intellectual
property portfolio covered 398 titles worldwide divided
into 58 patent families for its innovation in enzymatic recycling
of PET plastics and fibers, and its PLA biodegradation
technology.
CSR policy
In June 2023, we integrated our Purpose
into the bylaws of the Company, as permitted by the PACTE
Act of 2019, following the vote at the Annual General Meeting held
on 22 June 2023, namely "to generate a positive and
significant social, societal and environmental impact in the
conduct of its activities". This Purpose underpins
CARBIOS' business, which provides solutions to the environmental
emergency of tackling plastic pollution.
In December 2023, we published our
second Sustainability Report. Like the
first, this report is not subject to any publication obligation for
the company but confirms CARBIOS' commitment and desire for
transparency in terms of environmental, social and governance (ESG)
initiatives. Going beyond the industrial development of its
innovative technologies, the company shares its progress and
ambitions for the future.
In April 2024, CARBIOS announced the
success of its first employee share scheme for all
employees of the Group who are members of the savings plan in
France. Launched on 12 February 2024, 123 employees subscribed,
representing 88.49% of the eligible workforce, thereby enabling
employees to participate in the Group’s growth and performance. As
a result, CARBIOS’ employee share ownership, within the meaning of
the Article L. 225-102 of the French Commercial Code, now stands at
around 0,08% of the share capital.
Strengthening governance
Change in the Board of
Directors
In February 2023,
CARBIOS announced the cooptation, within its Board of Directors, of
Karine Auclair, professor of Chemistry at McGill
University, Mateus Schreiner Garcez Lopes, Global
Director for Energy Transition and Investments at Raizen,
Amandine De Souza, General Manager of leboncoin
and Sandrine Conseiller, CEO of De Beers Brands
and former CEO of Aigle, as independent members of CARBIOS’ Board
of Directors.
To date, the Company
has seven independent Directors, i.e. 63.64% of the total number of
Directors.
Change in the Executive Committee
In October 2023, we strengthened our leadership
team with the appointment of Bénédicte Garbil as Senior
Vice President of Corporate Affairs, Sustainability and
Communication. As a member of the CARBIOS Executive
Committee, Bénédicte Garbil oversees three strategic areas: Public
Affairs, Corporate Affairs, and Sustainability. In her Corporate
Affairs role, she supervises Communication, Regulatory, Project
Management, and Innovation Funding functions. In her Sustainability
role, she oversees CSR8, QHSE9, and LCA10 functions.
Awards
In May 2023, CARBIOS
was selected to represent French innovation at the
6th “Choose France”
Summit at the Château de Versailles. “Choose France”
is an international business summit dedicated to the attractiveness
of France launched at the initiative of the French President,
Emmanuel Macron. On this occasion, CARBIOS announced that it had
joined the Coq Vert community launched by
Bpifrance in partnership with ADEME and the Ministry of Ecological
Transition, to connect with other environmentally committed
business leaders and advance its international deployment.
In November 2023,
together with our partner L'Oréal, the world’s leading beauty
player, we won the "Pioneer Awards" in the
Industry category, presented by the Solar
Impulse Foundation at the first World Alliance
Summit. This prestigious prize was awarded to CARBIOS for
its enzymatic PET recycling solution, labeled "Efficient Solution"
by the Solar Impulse Foundation since 2019, and to L'Oréal for
using this breakthrough technology for the first time in a
cosmetics bottle prototype. CARBIOS' solution offers brands an
alternative to petro-sourced plastic that helps them meet their
sustainability commitments.
In March 2024, CARBIOS
has been awarded the Small & Mid Cap 2023 Secondary
Transaction award by Euronext. This award recognizes the
success of CARBIOS’ €141 million rights issue, which was the
largest transaction carried out on Euronext Growth since 2015.
Outlook – confirmation of industrial and
commercial objectives
Given the significant
progress made by the Group during 2023 and the success of the
financing operation closed in July 2023 as well as the received
grants, CARBIOS confirms its operating targets and the provisional
calendar of the industrial and commercial deployment of its PET
biorecycling technology11.
2024 • Construction
of the Longlaville plant further to permits obtained in October
20232024 •
Recruitment of plant operations team and training at demonstration
facility2026 • First
significant deliveries to clients
Alongside this
project, CARBIOS aims to sign its first licensing contracts for its
PET biorecycling technology in 2024.
###
About CARBIOS:
CARBIOS is a biotech company developing and
industrializing biological solutions to reinvent the life cycle of
plastic and textiles. Inspired by nature, CARBIOS develops
enzyme-based processes to break down plastic with a mission to
avoid plastic and textile pollution, and accelerate the transition
to a circular economy. Its two disruptive technologies for the
biorecycling of PET and the biodegradation of PLA are reaching
industrial and commercial scale. Its biorecycling
demonstration plant has been operational since 2021 and a first
industrial plant is currently under construction in partnership
with Indorama Ventures. CARBIOS has received scientific
recognition, notably with the cover of Nature, and is supported by
prestigious brands in the cosmetics, Food & Beverage and
apparel industries to enhance their products’ recyclability and
circularity. Nestlé Waters, PepsiCo and Suntory Beverage & Food
Europe are members of a packaging consortium founded by CARBIOS and
L’Oréal. On, Patagonia, PUMA, PVH Corp. and Salomon collaborate
with CARBIOS in a textile consortium.Visit www.CARBIOS.com/en to
find out more about biotechnology powering plastic and textile
circularity.Twitter: CARBIOS / LinkedIn: CARBIOS / Instagram:
insideCARBIOS
Information on CARBIOS shares:
ISIN Code
FR0011648716Ticker
Code
Euronext
Growth: ALCRBLEI:
969500M2RCIWO4NO5F08
CARBIOS, founded in 2011 by Truffle Capital, is eligible for the
PEA-PME, a government program allowing French residents investing
in SMEs to benefit from income tax rebates.
Disclaimer on forward-looking statements
and risk factors:This press release contains
forward-looking statements, not historical data, and should not be
construed as a guarantee that the facts and data stated will occur.
These forward-looking statements are based on data, assumptions and
estimates considered reasonable by CARBIOS. CARBIOS operates in a
competitive and rapidly evolving environment. It is therefore not
in a position to anticipate all risks, uncertainties or other
factors that may affect its business, their potential impact on its
business or the extent to which the materialization of a risk or
combination of risks could lead to results that differ
significantly from those mentioned in any forward-looking
statement. CARBIOS draws your attention to the fact that
forward-looking statements are in no way a guarantee of its future
performance and that its actual financial position, results and
cash flows and the development of the sector in which CARBIOS
operates may differ significantly from those proposed or suggested
by the forward-looking statements contained in this document. In
addition, even if CARBIOS’ financial position, results, cash flows
and developments in the industry in which it operates are
consistent with the forward-looking information contained in this
document, such results or developments may not be a reliable
indication of CARBIOS’ future results or developments. Readers are
advised to carefully consider the risk factors described in the
Universal registration document filed with the French Market
Authority (“AMF”), as well as in the half-year financial report
available free of charge on the Company’s website. Should all or
any part of these risk factors materialize or others, in no case
whatsoever will CARBIOS be liable to anyone for any decision made
or action taken in conjunction with the information and/or
statements in this press release or for any related damages. This
information is given only as of the date of this press release.
CARBIOS makes no commitment to publish updates to this information
or on the assumptions on which it is based, except in accordance
with any legal or regulatory obligation applicable to it.
For additional information, please
contact:
CARBIOS |
Press Relations (France) |
Press Relations (U.S) |
Press Relations (DACH & UK) |
Melissa Flauraud |
Iconic |
Rooney Partners |
MC Services |
Press Relations |
Marie-Virginie Klein |
Kate L. Barrette |
Anne-Hennecke |
Melissa.flauraud@corbios.com |
mvk@iconic-conseil.com |
kbarrette@rooneyco.com |
carbios@mc-services.eu |
+33 (0)6 30 26 50 04 |
+33 (0)1 44 14 99 96 |
+1 212 223 0561 |
+49 (0)211 529 252 22 |
Benjamin Audebert |
|
|
|
Investor Relations |
|
|
|
contact@carbios.com |
|
|
|
+33 (0)4 73 86 51 76 |
|
|
|
This press release does not constitute and cannot
be regarded as constituting an offer to the public, an offer to
sell or a subscription offer or as a solicitation to solicit a buy
or sell order in any country.
Translation for information purposes only. In
case of discrepancy between the French and the English version of
this press release, the French version shall prevail.
1 PET = polyethylene terephthalate2 Wholly-owned subsidiary of
Carbios for its industrial operations in Longlaville3 The
implementation of this funding is conditional to the European
Commission's approval of the corresponding state aid scheme,
followed by the conclusion of national aid agreements.4 Further
information on the capital increase, successfully completed in July
2023, can be found in the prospectus approved by the Autorité des
marchés financiers (AMF) on June 21, 2023, under number 23-236,
which is available free of charge from the CARBIOS
(https://investir.CARBIOS.com) and the AMF (www.amf-france.org/fr)
websites.
5 Ellen MacArthur Foundation, 20176
Fiber-to-fiber recycling transforms textile waste into new fibers
for clothing and textiles, with no loss in quality7 Technological
Information Summary8 CSR = Corporate Social Responsibility9 QHSE =
Quality, Health, Security, Environment10 LCA = Life Cycle
Analysis11 Estimated dates subject to the terms remaining to be
defined for the collaboration between CARBIOS and Indorama
Ventures
- 2024 04 11_PR_FY Results 2023 Final
Carbios (EU:ALCRB)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024
Carbios (EU:ALCRB)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024